Apolipoprotein C-III in patients with systemic lupus erythematosus

Abstract Background Systemic lupus erythematosus (SLE) has been associated with atherosclerotic cardiovascular disease (CV) and an altered lipid profile. High levels of apolipoprotein C-III (ApoC3) are associated with elevated triglyceride levels and an increased risk of CV. In the present study, we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Candelaria Martín-González, Carmen Ferrer-Moure, Juan Carlos Quevedo-Abeledo, Antonia de Vera-González, Alejandra González-Delgado, Julio Sánchez-Martín, Miguel Á. González-Gay, Iván Ferraz-Amaro
Format: Artigo
Idioma:Inglês
Publicat: BMC 2022-05-01
Col·lecció:Arthritis Research & Therapy
Matèries:
Systemic lupus erythematosus
Apolipoprotein C3
Accés en línia:https://doi.org/10.1186/s13075-022-02793-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars